Comparison of early tumor shrinkage between oxaliplatin plus S-1 and cisplatin plus S-1 in first-line chemotherapy with advanced gastric cancer.

被引:0
|
作者
Osumi, Hiroki [1 ]
Takahari, Daisuke [1 ]
Shinozaki, Eiji [1 ]
Chin, Keisho [1 ]
Ogura, Mariko [1 ]
Nakayama, Izuma [1 ]
Matsushima, Tomohiro [1 ]
Wakatsuki, Takeru [1 ]
Ichimura, Takashi [1 ]
Suenaga, Mitsukuni [1 ]
Yamaguchi, Kensei [1 ]
机构
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan
关键词
D O I
10.1200/JCO.2017.35.4_suppl.75
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
75
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Adjuvant Chemotherapy With S-1 Plus Docetaxel Versus S-1 Plus Oxaliplatin in Stage III Gastric Cancer
    Yamamoto, Masaaki
    Omori, Takeshi
    Shinno, Naoki
    Hara, Hisashi
    Mukai, Yosuke
    Sugase, Takahito
    Takeoka, Tomohira
    Mikamori, Manabu
    Kanemura, Takashi
    Hasegawa, Shinichiro
    Akita, Hirofumi
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Wada, Hiroshi
    Matsuda, Chu
    Yasui, Masayoshi
    Miyata, Hiroshi
    Ohue, Masayuki
    ANTICANCER RESEARCH, 2023, 43 (11) : 5015 - 5024
  • [22] S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial
    Kang, Yoon-Koo
    Chin, Keisho
    Chung, Hyun Cheol
    Kadowaki, Shigenori
    Oh, Sang Cheul
    Nakayama, Norisuke
    Lee, Keun-Wook
    Hara, Hiroki
    Chung, Ik-Joo
    Tsuda, Masahiro
    Park, Se Hoon
    Hosaka, Hisashi
    Hironaka, Shuichi
    Miyata, Yoshinori
    Ryu, Min-Hee
    Baba, Hideo
    Hyodo, Ichinosuke
    Bang, Yung-Jue
    Boku, Narikazu
    LANCET ONCOLOGY, 2020, 21 (08): : 1045 - 1056
  • [23] Impact of S-1 plus cisplatin neoadjuvant chemotherapy in scirrhous gastric cancer.
    Kunisaki, Chikara
    Makino, Hirochika
    Kimura, Jun
    Takagawa, Ryo
    Kanazawa, Amane
    Oshima, Takashi
    Ota, Mitsuyoshi
    Kosaka, Takashi
    Ono, Hidetaka
    Akiyama, Hirotoshi
    Endo, Itaru
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [24] A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer
    Toshikazu Moriwaki
    Shinji Hirai
    Shuichi Hironaka
    Kenji Amagai
    Atsuko Soeda
    Mikio Sato
    Takeshi Nihei
    Mitsuaki Hirose
    Kenji Matsuda
    Atsushi Ohkawara
    Taketo Yamaguchi
    Mitsuharu Ozeki
    Takashi Mamiya
    Tetsuya Murashita
    Ichinosuke Hyodo
    Gastric Cancer, 2014, 17 : 354 - 361
  • [25] A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer
    Moriwaki, Toshikazu
    Hirai, Shinji
    Hironaka, Shuichi
    Amagai, Kenji
    Soeda, Atsuko
    Sato, Mikio
    Nihei, Takeshi
    Hirose, Mitsuaki
    Matsuda, Kenji
    Ohkawara, Atsushi
    Yamaguchi, Taketo
    Ozeki, Mitsuharu
    Mamiya, Takashi
    Murashita, Tetsuya
    Hyodo, Ichinosuke
    GASTRIC CANCER, 2014, 17 (02) : 354 - 361
  • [26] S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
    Koizumi, Wasaburo
    Narahara, Hiroyuki
    Hara, Takuo
    Takagane, Akinori
    Akiya, Toshikazu
    Takagi, Masakazu
    Miyashita, Kosei
    Nishizaki, Takashi
    Kobayashi, Osamu
    Takiyama, Wataru
    Toh, Yasushi
    Nagaie, Takashi
    Takagi, Seiichi
    Yamamura, Yoshitaka
    Yanaoka, Kimihiko
    Orita, Hiroyuki
    Takeuchi, Masahiro
    LANCET ONCOLOGY, 2008, 9 (03): : 215 - 221
  • [27] A phase III study of TAS-118 plus oxaliplatin versus S-1 plus cisplatin as first-line chemotherapy in patients with advanced gastric cancer (SOLAR study)
    Kang, Y.
    Chin, K.
    Chung, H.
    Kadowaki, S.
    Oh, S.
    Nakayama, N.
    Lee, K.
    Hara, H.
    Chung, I.
    Tsuda, M.
    Park, S.
    Hosaka, H.
    Hironaka, S.
    Miyata, Y.
    Ryu, M.
    Takeuchi, M.
    Baba, H.
    Hyodo, I.
    Bang, Y.
    Boku, N.
    ANNALS OF ONCOLOGY, 2019, 30
  • [28] Safety and efficacy of neoadjuvant chemotherapy with S-1 and oxaliplatin plus apatinib for locally advanced gastric cancer.
    Zheng, Ya'nan
    Yang, Xiao
    Ni, Zhentian
    Zhu, Zhenglun
    Xu, Wei
    Yang, Zhongyin
    Liu, Wentao
    Yan, Min
    Zhu, Zhenggang
    Li, Chen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial)
    Lee, Keun-Wook
    Chung, Ik-Joo
    Ryu, Min-Hee
    Park, Young Iee
    Nam, Byung-Ho
    Oh, Ho-Suk
    Lee, Kyung Hee
    Han, Hye Sook
    Seo, Bong-Gun
    Jo, Jae-Cheol
    Lee, Hyo Rak
    Kim, Jin Won
    Park, Sook Ryun
    Cho, Sang Hee
    Kang, Yoon-Koo
    GASTRIC CANCER, 2021, 24 (01) : 156 - 167
  • [30] Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial)
    Keun-Wook Lee
    Ik-Joo Chung
    Min-Hee Ryu
    Young Iee Park
    Byung-Ho Nam
    Ho-Suk Oh
    Kyung Hee Lee
    Hye Sook Han
    Bong-Gun Seo
    Jae-Cheol Jo
    Hyo Rak Lee
    Jin Won Kim
    Sook Ryun Park
    Sang Hee Cho
    Yoon-Koo Kang
    Gastric Cancer, 2021, 24 : 156 - 167